Trials / Completed
CompletedNCT00189228
Immune Dysfunction in Allergic Asthma
Not a Drug Trial. We Are Using Anti-IgE to Examine the Role of Pulmonary Mast Cells in Asthma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- University of New Mexico · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
We are using anti-IgE to investigate the role of pulmonary mast cells in asthma.
Detailed description
Subjects with mild allergic asthma are examined before, immediately after and 2 months after a course of treatment with anti-IgE. The following are examined: Allergen skin tests, allergen induced asthma, peripheral blood basophils, pulmonary bronchial mucosal mast cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xolair | Patients are administered Xolair |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2005-09-16
- Last updated
- 2019-09-27
- Results posted
- 2019-09-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00189228. Inclusion in this directory is not an endorsement.